Coloplast A/S
(WBO:COLO)
€
113.35
2.05 (1.84%)
Market Cap: 25.50 Bil
Enterprise Value: 28.67 Bil
PE Ratio: 37.72
PB Ratio: 11.74
GF Score: 90/100 - Q2 2024 Coloplast A/S Earnings Call TranscriptMay 07, 2024€113.4 (-3.16%)Earnings
- Q1 2024 Coloplast A/S Earnings Call TranscriptFeb 09, 2024€120 (+10.14%)Earnings
- Q4 2023 Coloplast A/S Earnings Call TranscriptNov 09, 2023€96.48 (-6.69%)Earnings
- Coloplast A/S to Discuss Complete Acquisition of Kerecis Call TranscriptSep 04, 2023
- Q3 2023 Coloplast A/S Earnings Call TranscriptAug 17, 2023€108.85 (-1.40%)Earnings
- Coloplast A/S Announces Agreement to Acquire Kerecis Call TranscriptJul 07, 2023
- Q2 2023 Coloplast A/S Earnings Call TranscriptMay 11, 2023€125.3 (-4.39%)Earnings
- Q1 2023 Coloplast A/S Earnings Call TranscriptFeb 03, 2023€113.55 (-1.13%)Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 01, 2022
- Q4 2022 Coloplast A/S Earnings Call TranscriptNov 07, 2022€106.5 (-2.65%)Earnings
- Coloplast A/S Meet the Management Event TranscriptAug 31, 2022
- Q3 2022 Coloplast A/S Earnings Call TranscriptAug 17, 2022€119 (+5.54%)Earnings
- Q2 2022 Coloplast A/S Earnings Call TranscriptMay 05, 2022€136.5Earnings
- Coloplast A/S Virtual ESG Event Call TranscriptMar 22, 2022
- Q1 2022 Coloplast A/S Earnings Call TranscriptJan 25, 2022€129.35 (+2.50%)Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 02, 2021
- Coloplast A/S to Acquire Atos Medical Call TranscriptNov 08, 2021
- Q4 2021 Coloplast A/S Earnings Call TranscriptNov 01, 2021€138.65 (-2.26%)Earnings
- Q3 2021 Coloplast A/S Earnings Call TranscriptAug 18, 2021€147.65 (-3.81%)Earnings
- Q2 2021 Coloplast A/S Earnings Call TranscriptMay 06, 2021€131.55 (-5.43%)Earnings
- Q1 2021 Coloplast A/S Earnings Call TranscriptFeb 02, 2021€136.9 (+8.74%)Earnings
- Coloplast A/S at JPMorgan Healthcare Conference (Virtual) TranscriptJan 14, 2021
- Q4 2020 Coloplast A/S Earnings Call TranscriptNov 03, 2020€123.1 (-2.73%)Earnings
- Coloplast A/S Virtual Sustainability Deep-Dive Session TranscriptOct 09, 2020
- Coloplast A/S Virtual Deep-Dive Sessions TranscriptOct 07, 2020
- Coloplast A/S Virtual Capital Markets Day TranscriptSep 29, 2020
- Q3 2020 Coloplast A/S Earnings Call TranscriptAug 18, 2020€136 (-2.23%)Earnings
- Coloplast A/S at UBS Global Healthcare Conference (Virtual) TranscriptMay 20, 2020
- Q2 2020 Coloplast A/S Earnings Call TranscriptMay 06, 2020€139.65 (-3.62%)Earnings
- Coloplast A/S Revised Full Year Organic Growth and EBIT Margin Guidance for 2019/2020 Call TranscriptMar 19, 2020
- Q1 2020 Coloplast A/S Earnings Call TranscriptFeb 06, 2020€121.4 (+3.58%)Earnings
- Coloplast A/S Annual Shareholders Meeting TranscriptDec 05, 2019
- Q4 2019 Coloplast A/S Earnings Call TranscriptNov 05, 2019€106.35 (-4.28%)Earnings
- Coloplast A/S Meet the Management Event TranscriptAug 20, 2019
- Q3 2019 Coloplast A/S Earnings Call TranscriptAug 14, 2019€107.6 (+1.41%)Earnings
- Q2 2019 Coloplast A/S Earnings Call TranscriptMay 02, 2019€93.28 (-3.04%)Earnings
Coloplast A/S at JPMorgan Healthcare Conference (Virtual) Transcript
Jan 14, 2021 / 04:40PM GMT
Release Date Price:
€119.7
(+0.59%)
David James Adlington
JPMorgan Chase & Co, Research Division - Head of Medical Technology and Services Equity Research
Good morning, everybody. Welcome. It's David Adlington again from the JPMorgan med tech team in Europe. It's my pleasure to introduce CEO of Coloplast, Kristian Villumsen, for this latest session. (Operator Instructions)
Kristian, thanks for joining us today, and over to you for the presentation.
Kristian Villumsen;S;President;CEO
Coloplast A
/-&
Thank you very much, David. Can I just check that you hear me loud and clear?
David James Adlington
JPMorgan Chase & Co, Research Division - Head of Medical Technology and Services Equity Research
Yes. Perfect.
Kristian Villumsen;S;President;CEO
Coloplast A
/-&
Very good. So I'll speak for about 20 minutes for the benefit of the people participating who may not know the company so well. And
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)